Penn Medicine Abramson Cancer Center Updates on Managing CLL/SLL With Practical Considerations for Novel Agents | VuMedi

Penn Medicine Abramson Cancer Center

Penn Medicine Abramson Cancer Center Updates on Managing CLL/SLL With Practical Considerations for Novel Agents

By Penn Medicine Abramson Cancer Center FEATURING Jordan Carter, Mitchell Hughes

By Penn Medicine Abramson Cancer Center FEATURING Jordan Carter, Mitchell Hughes

368 views

January 19, 2024

Overview of CLL/SLL, Signs & Symptoms

00:00

Risk Factors & Diagnosing CLL/SLL

02:33

Genetic Testing & Prognostic Factors in CLL

03:44

Rai & Binet Staging Systems for CLL

09:11

Complications from CLL & Approach to Treatment

10:11

BTK Inhibitors for CLL: Ibrutinib, Acalabrutinib & Zanubrutinib

15:59

Venetoclax-Based Therapy & Side Effects

21:47

Anti-CD20 Monoclonal Antibody Therapy for CLL

25:23

Emerging Treatments & Complications Management for CLL

26:55

Comments 0

Login to view comments. Click here to Login